Algorithms, Patient Management, AMI Cardiogenic Shock

Achieving >70% AMICS Survival: Insights From National Cardiogenic Shock Initiative Study

 

William O’Neill, MD, discusses insights from the National Cardiogenic Shock Initiative (NCSI) Study which is driving improvement in outcomes in patients with AMI cardiogenic shock (AMICS). Dr. O’Neill describes the algorithm and explains how cardiac power output (CPO) and pulmonary artery pulsatility index (PAPi) are used to drive care for patients after angioplasty. He then discusses the following key learnings from the NCSI Study:

  • Identify and support cardiogenic shock early
  • Aggressively down-titrate inotropes
  • Identify inadequate LV support and escalate – “If CPO <0.8, you must escalate!”
  • Identify RV dysfunction early and support
  • Systematically use right heart catheter (RHC)/pulmonary artery catheter (PAC) to guide therapy

Dr. O’Neill is medical director of the Center for Structural Heart Disease, Henry Ford System, Detroit, Michigan.

 

 

View more resources

IMP-1759

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].